212

ALENDRONATE

Find entries where: 212

is present as a standalone ligand in 2 entries

Find related ligands:

Chemical Component Summary
Name	ALENDRONATE
Synonyms	(4-AMINO-1-HYDROXY-1-PHOSPHONO-BUTYL)PHOSPHONIC ACID
Identifiers	(4-amino-1-hydroxy-1-phosphono-butyl)phosphonic acid
Formula	C₄ H₁₃ N O₇ P₂
Molecular Weight	249.096
Type	NON-POLYMER
Isomeric SMILES	C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN
InChI	InChI=1S/C4H13NO7P2/c5-3-1-2-4(6,13(7,8)9)14(10,11)12/h6H,1-3,5H2,(H2,7,8,9)(H2,10,11,12)
InChIKey	OGSPWJRAVKPPFI-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	27
Chiral Atom Count	0
Bond Count	26
Aromatic Bond Count	0

Drug Info: DrugBank

DrugBank ID	DB00630
Name	Alendronic acid
Groups	approved
Description	Alendronic acid is a second generation bisphosphonate that is used for the treatment of some forms of osteoperosis and Paget's disease[FDA Label][A959,A203111]. It functions by preventing resorption of bone[FDA Label][A959].
Synonyms	Alendronate sodium anhydrous Alendronate ABDP Alendronic acid Alendronate calcium (4-amino-1-hydroxybutylidene)bisphosphonic acid Acido Alendronico (4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid) Alendronate sodium Acide Alendronique 4-amino-1-hydroxybutane-1,1-diphosphonic acid Acidum Alendronicum Alendronate disodium
Brand Names	M-alendronate Ratio Alendronate Auro-alendronate Teva-alendronate/cholecalciferol Jamp-alendronate Van-alendronate Teva-alendronate Alendronate Ran-alendronate Act Alendronate Jamp Alendronate Sodium Q-alendronate Vantavo Nra-alendronate Alendronate-cholecalciferol Apo-alendronate Mint-alendronate Apo-alendronate/vitamin D3 Adrovance Fosamax Accel-alendronate Ag-alendronate Sodium Fosavance Mylan-alendronate Riva-alendronate Sandoz Alendronate Ach-alendronate Alendronate Sodium Ava-alendronate PHL-alendronate Dom-alendronate-FC Fosamax Plus D Sandoz Alendronate/cholecalciferol Binosto Alendronate-70 Gen-alendronate PMS-alendronate Jamp Alendronate / Vitamin D3 Ag-alendronate Dom-alendronate PMS-alendronate-FC Riva Alendronate
Indication	Alendronic acid is indicated for the treatment and prevention of osteoporosis in men and postmenopausal women, treatment of glucocorticoid-induced osteoporosis, and Paget's disease of bone[FDA Label][A959,A176750]. However, alendronic acid is not indicated for use in pediatric populations or patients with a creatinine clearance <35mL/min[FDA Label].
Categories	Agents Causing Muscle Toxicity Bisphosphonates Bone Density Conservation Agents Drugs Affecting Bone Structure and Mineralization Drugs for Treatment of Bone Diseases Musculo-Skeletal System Organophosphonates Organophosphorus Compounds
ATC-Code	M05BB03 M05BA04 M05BB06 M05BB05
CAS number	66376-36-1

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Farnesyl pyrophosphate synthase	MPLSRWLRSVGVFLLPAPYWAPRERWLGSLRRPSLVHGYPVLAWHSARCW...	unknown	inhibitor
Hydroxylapatite	-	unknown	antagonist
Tyrosine-protein phosphatase non-receptor type 4	MTSRFRLPAGRTYNVRASELARDRQHTEVVCNILLLDNTVQAFKVNKHDQ...	unknown	inhibitor
Receptor-type tyrosine-protein phosphatase S	MAPTWGPGMVSVVGPMGLLVVLLVGGCAAEEPPRFIKEPKDQIGVSGGVA...	unknown	inhibitor
Receptor-type tyrosine-protein phosphatase epsilon	MEPLCPLLLVGFSLPLARALRGNETTADSNETTTTSGPPDPGASQPLLAW...	unknown	inhibitor
V-type proton ATPase catalytic subunit A	MDFSKLPKILDEDKESTFGYVHGVSGPVVTACDMAGAAMYELVRVGHSEL...	unknown	inhibitor
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682